. . "2007-08-08+02:00"^^ . "Byla vyu\u017Eita technologie monolitn\u00EDch kolon pro v\u00FDvoj HPLC metod stanoven\u00ED vitam\u00EDn\u016F A, E, ester\u016F retinolu v s\u00E9ru, vitam\u00EDnu C v plazm\u011B a neopterinu v mo\u010Di pro zkvalitn\u011Bn\u00ED diagnostiky onkologick\u00FDch, KVS a metabolick\u00FDch chorob u geront\u016F"@cs . "Mechanismy st\u00E1rnut\u00ED - aplikace technologie monolitn\u00EDch kolon v HPLC anal\u00FDze biologicky aktivn\u00EDch l\u00E1tek v gerontologii" . . "http://www.isvav.cz/projectDetail.do?rowId=NR8048"^^ . "monolithic columns; HPLC; aging; atherosclerosis; vitamin E; neopterin; oncology"@en . . . " neopterin" . " aging" . . . . "Mechanisms of aging - the application of monolithic column technology in HPLC analysis of biologically active substances in gerontology"@en . . "The technol.of monolithic colomn was used to develop the HPLC meth.for serum vit.A,E,retinyl estres,plasma vit.C +urine neopterin determination.Quest to find improve the quality of diagnosis of cancer,cardiovascular and metabolic diseases in gerontology."@en . "11"^^ . "11"^^ . . . . . . " atherosclerosis" . . "monolithic columns" . "The monolithic columns represent the new revolution trend in chromatography. The discovery of this technology opens the new possibilities in analytical chemistry. The use of the modern monolithic technology in HPLC analysis of biological active substances for clinical research of cardiovascular, cancer and metabolic diseases in gerontology. To develop the modern analytical procedures in clinical studies and to improve the quality of diagnosis of chronically illnesses and care with aim to reduce the expenses of the treatment in the elderly."@en . "NR8048" . " vitamin E" . "0"^^ . . . "0"^^ . . "1"^^ . . "Monolitn\u00ED kolony p\u0159edstavuj\u00ED revolu\u010Dn\u00ED sm\u011Br v chromatografii. Objev t\u00E9to technologie otev\u00EDr\u00E1 nov\u00E9 mo\u017Enosti aplikac\u00ED analytick\u00E9 chemie v klinick\u00E9 medic\u00EDn\u011B. C\u00EDlem projektu je vyu\u017Eit\u00ED modern\u00EDch monolitn\u00EDch technologi\u00ED pro HPLC anal\u00FDzu biologicky aktivn\u00EDch l\u00E1tek v klinick\u00E9m sledov\u00E1n\u00ED, diagnostice a monitoraci pr\u016Fb\u011Bhu onkologick\u00FDch, kardiovaskul\u00E1rn\u00EDch a metabolick\u00FDch chorob u pacient\u016F z vy\u0161\u0161\u00EDch v\u011Bkov\u00FDch skupin. Zlep\u0161en\u00ED laboratorn\u00ED diagnostiky chronick\u00FDch chorob aplikac\u00ED modern\u00EDch analytick\u00FDch postup\u016F v klinick\u00E9m sledov\u00E1n\u00ED dos\u00E1hnout zefektivn\u011Bn\u00ED v\u00FDdaj\u016F na p\u00E9\u010Di o star\u0161\u00ED populaci a zkvalitn\u011Bn\u00ED p\u00E9\u010De o tyto pacienty." . . " HPLC" . .